Cooper : 2Q25 Guidance Slide FINAL

Published: 2025-05-29 23:22:04 ET COO

Published on 05/29/2025 at 23:22

‌CooperCompanies

Organic Growth vs. FY24

FY25 Guidance

Revenue

Fiscal 2025 financial guidance

Total

$4,107 - $4,146

5% - 6%

CooperVision

$2,759 - $2,786

6% - 7%

CooperSurgical

$1,347 - $1,359

3.5% - 4.5%

Non-GAAP

$4.05 - $4.11

EPS

Notes: Sales $ in millions

Guidance updated 5/29/25.

Revenue growth is organic and non-GAAP EPS growth excludes FX. Organic growth is defined as constant currency excluding the impact of acquisitions and discontinuations

1

that occurred in the comparable period. A reconciliation of non-GAAP measures is available under the "Reconciliation of Selected GAAP Results to Non- GAAP Results" section in our earning releases and under the "Management's Discussion and Analysis of Financial Condition and Results of Operations" section in our Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, copies of which are available on our website: https://www.coopercos.com. With respect to EPS guidance, the Company has not provided reconciliation to GAAP due to the inherent difficulty in forecasting acquisition-related, integration and restructuring charges and expenses. Due to the unknown effect, timing and potential significance of such charges and expenses that impact GAAP diluted earnings per share, we are not able to provide such guidance.

Disclaimer

The Cooper Companies Inc. published this content on May 30, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 30, 2025 at 03:21 UTC.